Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Artivion (AORT) Research & Development (2016 - 2025)

Artivion (AORT) has disclosed Research & Development for 16 consecutive years, with $9.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Research & Development rose 23.2% year-over-year to $9.1 million, compared with a TTM value of $31.0 million through Dec 2025, up 8.92%, and an annual FY2025 reading of $31.0 million, up 8.92% over the prior year.
  • Research & Development was $9.1 million for Q4 2025 at Artivion, up from $8.1 million in the prior quarter.
  • Across five years, Research & Development topped out at $11.8 million in Q3 2022 and bottomed at $6.4 million in Q3 2023.
  • Average Research & Development over 5 years is $8.1 million, with a median of $7.7 million recorded in 2021.
  • The sharpest move saw Research & Development soared 73.28% in 2021, then plummeted 45.58% in 2023.
  • Year by year, Research & Development stood at $9.5 million in 2021, then decreased by 12.22% to $8.3 million in 2022, then dropped by 7.94% to $7.6 million in 2023, then decreased by 3.15% to $7.4 million in 2024, then rose by 23.2% to $9.1 million in 2025.
  • Business Quant data shows Research & Development for AORT at $9.1 million in Q4 2025, $8.1 million in Q3 2025, and $7.1 million in Q2 2025.